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Summary
We measured extracellular volume fraction (Ve) from
pre- and post-contrast T1 maps of the left ventricle in
13 patients with systemic sclerosis (SSc) and 13 age-
matched controls. SSc patients and controls were similar
with regard to LV and RV mass, volumes, and function.
However, Ve was significantly higher in SSc patients
than in controls, even when patients with visible late
gadolinium enhancement were excluded. Ve correlated
with SSc severity as measured by the modified Rodnan
Skin Score. Ve may be valuable for detection of myocar-
dial involvement in SSc, even when conventional CMR
appears normal.
Background
Primary cardiac involvement is common in systemic
sclerosis (SSc) and responsible for 25% of deaths. Myo-
cardial extracellular volume fraction (Ve), derived from
cardiac magnetic resonance (CMR) T1 mapping of the
myocardium, has been shown to quantify diffuse myo-
cardial fibrosis (DMF) - but its utility in SSc has not
been studied. We hypothesized that subjects with SSc
have a higher Ve compared to controls and that patients
with worse SSc severity have higher Ve.
Methods
CMR was performed in 13 SSc patients (5 diffuse and 8
limited cutaneous) and 13 age-matched controls. Cine,
pre- and post- contrast T1 mapping, and late gadoli-
nium enhanced (LGE) imaging was performed. LV mass
index (LVMi), LV end-diastolic volume index (LVEDVi),
LV ejection fraction (EF), RV mass index (RVMi), RV
end-diastolic volume index (RVEDVi), RV ejection frac-
tion (RVEF) and LGE as a percent of the LV (LGE%)
were quantified (Medis QMass MR 7.2). Ve was calcu-
lated as Ve = [ΔR1myocardium/ΔR1bloodpool × p × (1
- hematocrit)] - Vp, where R1 = 1/ T1, ΔR1 is post-con-
trast - precontrast R1, p is myocardial specific density
(1.05), and Vp is myocardial plasma volume fraction
(0.045). Skin involvement was quantified in all SSc
patients using the Modified Rodnan Skin Score (mRSS)
by clinicians blinded to all CMR data.
Results
LGE was visible in 3/13 SSc and 0/13 controls. Ve was
significantly higher in SSc than controls, even when
patients with visible LGE were excluded (Table 1A). In
contrast, there was no significant difference between SSc
and controls with regards to LVEF, LVMi, LVEDVi,
RVMi, RV EDVi, or RVEF (Table 1B). Ve correlated sig-
nificantly with mRSS in SSc patients (figure).
Conclusions
This is the first study to demonstrate the utility of CMR
T1 mapping for identification of diffuse myocardial
fibrosis in SSc. Extracellular volume fraction measured
by CMR correlates with SSc severity measured by
mRSS. Ve identifies diffuse myocardial fibrosis in SSc
patients, even in the absen c eo fL G E .G i v e nt h eh i g h
mortality associated with clinically symptomatic myocar-
dial involvement in SSc, this technique may be valuable
for detection even when conventional CMR appears
normal.
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Table 1 Quantitative CMR in SSC and controls
Table 1A
Ve% (mean ± SD) Compared to Controls
All SSc Patients (n = 13) 27.4 ± 4.6 p = 0.0003
SSc without LGE (n = 10) 26.9 ± 4.0 p = 0.001
Controls (n = 13) 20.6 ± 3.3 NA
Table 1B
SSc (n = 13) (mean ± SD) Control (n = 13) (mean ± SD)
LV Mass Index (g/m
2) 39.8 ± 8.4 42.8 ± 5.9 p = 0.3
LV EDV Index (ml/m
2) 69.4 ± 17.1 76.1 ± 16.2 p = 0.3
LV EF (%) 59.9 ± 9.2 57.0 ± 5.1 p = 0.3
RV Mass Index (g/m
2) 29.6 ± 10.0 25.9 ± 10.5 p = 0.4
RV EDV index (ml/m
2) 75.2 ± 25.7 73.4 ± 20.8 p = 0.9
RV EF (%) 47.8 ± 15.2 52.8 ± 7.8 p = 0.3
LGE (% of LV) 2.6 ± 8.0 0.0 ± 0.0 p = 0.3
Figure 1
Lee et al. Journal of Cardiovascular Magnetic Resonance 2012, 14(Suppl 1):O28
http://www.jcmr-online.com/content/14/S1/O28
Page 2 of 2